Increasing the dose of transferred T cells (2.5 × 105 or 5 × 105 cells per mouse) resulted in a more rapid development of GVHD in control mice, while DUSP6-expressing T cells did not efficiently expand at these doses (Supplementary Fig. 29a–c). This evidence concerns the gene DUSP6 and graft versus host disease.